Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
出版年份 2020 全文链接
标题
Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
作者
关键词
-
出版物
Frontiers in Public Health
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-05-16
DOI
10.3389/fpubh.2020.00185
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Covid-19: what treatments are being investigated?
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
- (2020) Tao Chen et al. BMJ-British Medical Journal
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- From SARS to MERS, Thrusting Coronaviruses into the Spotlight
- (2019) Zhiqi Song et al. Viruses-Basel
- Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production
- (2019) Amanda J. Lee et al. Frontiers in Immunology
- Azithromycin modulates immune response of human monocyte-derived dendritic cells and CD4 + T cells
- (2016) Syh-Jae Lin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium
- (2016) James D. Porter et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients
- (2016) Mandy Menzel et al. Scientific Reports
- Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses
- (2015) Leonard B. Bacharier et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type I Interferons in Bacterial Infections: Taming of Myeloid Cells and Possible Implications for Autoimmunity
- (2014) Emily M. Eshleman et al. Frontiers in Immunology
- Azithromycin induces anti-viral responses in bronchial epithelial cells
- (2010) V. Gielen et al. EUROPEAN RESPIRATORY JOURNAL
- Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C
- (2010) Robert Roomer et al. HEPATOLOGY
- Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice
- (2009) J.-F. YANG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started